top of page

Search Results

Results found for "pain modeling"

  • Targeted Therapies to Reduce Side Effects in Modern Drug Development

    drawback of causing damage to healthy cells in the process, leading to side effects that can include pain

  • Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...

    To better understand the structural basis for this bias, we examined structural models of GPR35 and conducted of our study provide clues for the future design of isoform-specific GPR35 ligands that selectively modulate

  • Fentanyl and Xylazine: Why Breathing Fails in Overdose

    This new pairing is uniquely dangerous. Catherine’s work lays the foundation for designing better interventions, from preclinical models to clinical From Street Samples to Lab Models What makes Catherine’s research particularly powerful is how it stays collaborating with harm-reduction groups such as the Red Project in Grand Rapids , she ensures her models For Catherine, those numbers aren’t just statistics—they’re signals guiding how to build better models

  • To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from...

    molecular dynamic simulations "The δ-opioid receptor (DOR) is a critical pharmaceutical target for pain

  • Co-activation of GPCRs facilitate GIRK-dependent current

    The heterologous facilitation was modelled based on the known cooperative interaction between the G protein KEY POINTS: Inhibitory D2 and GABAB receptors modulate dopamine neuron activity through shared G protein-coupled

  • Why Dose-Response Curves Are Pharmacology’s Secret Weapon

    lecture walks you through: What dose-response curves are and why they’re indispensable How curve-fitting models

  • Targeting Intracellular Allosteric Sites in GPCRs

    Unlike orthosteric ligands that bind directly to the receptor's active site, allosteric modulators target Over the past decade, there has been a notable growth in the discovery of allosteric modulators for GPCRs functional and/or affinity for an orthosteric ligand; and negative allosteric modulators (NAMs), that SBI-553, an allosteric modulator of NTSR1, provides valuable insights into how allosteric modulation Allosteric modulation is gaining prominence in GPCR therapeutics, with the discovery of an intracellular

  • 📰 GPCR Weekly News, February 5 to 11, 2024

    , 2024 GPCR Activation and Signaling Constitutive activation mechanism of a class C GPCR Allosteric modulation Research GPCR-BERT: Interpreting Sequential Design of G Protein-Coupled Receptors Using Protein Language Models Protein-Coupled Receptors: Integrating Enhanced Sampling Molecular Dynamics Simulations and Markov State Models

  • What If the Most Important Part of Your Drug Isn’t What It Binds—But What It Does?

    through real-world experiments, decades of receptor pharmacology wisdom, and the cutting-edge operational model

  • Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone...

    Moreover, the main investigations into animal models and ongoing clinical trials using these unimolecular

  • 📰 GPCR Weekly News, January 8 to 14, 2024

    GPCRs in Neuroscience The Na+ leak channel NALCN controls spontaneous activity and mediates synaptic modulation learning Industry News Exscientia Unveils MolFlux: Empowering the ML Community in Molecular Predictive Modelling Executive Officer Unraveling GPCRs Conformations: A Leap in Drug Discovery with STAGS Machine Learning Model

  • Therapeutic validation of an orphan G protein‐coupled receptor

    Some studies have also reported GPR84 involvement in pain, atherosclerosis, and even metabolic disorders IM (3,3′‐methylenebis‐1H‐indole) has been identified as a positive allosteric modulator of GPR84, a metabolite

  • Chemokine receptor-targeted drug discovery: progress and challenges

    inappropriate target selection and insufficient dosing of chemokine receptor antagonists in vivo might be the main receptors can homo- and hetero-oligomerize, impacting receptor/ligand-binding and signaling patterns, by modulating These larger interfaces represent the typical protein-protein interactions which are difficult to modulate Overall, the future potential lies in using different therapeutic modalities to modulate the stromal

  • 📰 GPCR Weekly News, January 23 to 29, 2023

    Molecular Modeling Study of a Receptor-Orthosteric Ligand-Allosteric Modulator Signaling Complex. into GPCR Function Structural and dynamic insights into supra-physiological activation and allosteric modulation

  • 📰 GPCR Weekly News, April 22 to 28, 2024

    Signaling at the Endosome GPCR Binders, Drugs, and more Discovery and development of macrocyclic peptide modulators RNA NEAT1 in Alzheimer's disease Parenting behaviors in mice: Olfactory mechanisms and features in models Generation of a deep mouse brain spectral library for transmembrane proteome profiling in mental disease models

  • Beyond Clearance: The Strategic Power of Irreversible Drug Binding

    In this lesson, you'll gain: ✅ Clarity on what “irreversible” really means  in kinetic and pharmacologic Dose prediction models need kinetic nuance—not just Cmax and AUC. You can’t model irreversible binding with the usual tools.

  • 📰 GPCR Weekly News, November 6 to November 12, 2023

    promotes autistic-like behavior Acetate mitigates cardiac mitochondrial dysfunction in experimental model of polycystic ovarian syndrome by modulating GPCR41/43 and PROKR1 GPCRs in Neuroscience Diverse signaling Industry News Exscientia Business Update for Third Quarter 2023 Addex CEO Tim Dyer to Discuss Allosteric Modulators

  • Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR

    The study distinguishes between driver residues , which directly influence signal transduction, and modulator Alternatively, allosteric modulators , which bind to sites outside the traditional ligand-binding pocket Allosteric modulators offer a promising approach for developing drugs that enhance or inhibit receptor within the ligand-binding pocket, resulting in a significant opportunity for developing allosteric modulators Deep mutational scanning, for instance, is gaining popularity as a strategy due to its ability to comprehensively

  • Trevena Announce Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu ...

    United States by the Food and Drug Administration (FDA) for use in adults for the management of acute pain

  • Structural basis of adhesion GPCR GPR110 activation by stalk peptide and G-proteins coupling

    also known to be capable of self-activation via an autoproteolysis process that removes the inhibitory GAIN The structures reveal distinctive ligand engaging model and activation conformations of GPR110.

  • AlphaFold2 versus experimental structures: evaluation on G protein-coupled receptors

    Recently, AlphaFold2 has been developed to predict structure models of many functionally important proteins Herein we evaluated the accuracy of GPCR structure models predicted by AlphaFold2. However, the predicted models and experimental structures were different in many aspects including the These differences impeded the use of predicted structure models in the functional study and structure-based

  • GPCR Happy Hour – Boston, Sept 2025

    the discovery process, including its pioneering organellar electrophysiology platform, iPSC-derived models , optogenetics, and high-content screening techniques such as cell painting assays.

  • Dynamic recognition of naloxone, morphine and endomorphin1 in the same pocket of µ-opioid receptors

    September 2022 "Morphine, the most widely used analgesic, relieves severe pain by activating the μ-opioid

  • The Five Traps of Ignoring Kinetics

    In this session, you'll gain: ✅ Tools to confirm true equilibrium and avoid potency errors from premature If you detect it, you gain texture that equilibrium constants alone can’t provide. distilled from decades of pharmacology experience Whether you’re validating assays, refining kinetic models

  • 📰 GPCR Weekly News, January 1 to 7, 2024

    ortholog MRGPRB2 Metabolite-sensing GPCRs in rheumatoid arthritis Dissecting the molecular basis for the modulation protein-coupled receptor Methods & Updates in GPCR Research RediscMol: Benchmarking Molecular Generation Models leucine and isoleucine in tuning the hydropathy of class A GPCRs Arylsulfatases and neuraminidases modulate

  • Understanding the Journey: Catherine Demery's Path to Addiction Science

    After excelling in the PCAT and gaining admission to pharmacy school at the University of Michigan, it that environment, every project brought new challenges—deadlines, documentation, and deliverables for paying She gained exposure to in vivo models, immunology, and complex study design, while also getting closer

  • 📰 GPCR Weekly News, January 15 to 21, 2024

    Graham Ladds’ team refines AlphaFold models using binding calculations for human adenosine A3 receptor islets regulating somatostatin release and islet development GPCR Activation and Signaling In Vitro Module activation and signaling GPCR Binders, Drugs, and more Computational Workflow for Refining AlphaFold Models

  • Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence

    Must-read publications:  New insights on RGS protein modulation, GRK2-biased β₂AR signaling, and the Don't let misconceptions about receptor binding kinetics slow your progress—gain the clarity you need If you’re not there, you’re missing out on the next wave of allosteric modulators, biased ligands, and Gain a competitive edge by staying on top of the latest breakthroughs in allostery, biased signaling, Gain the insights, tools, and connections you need to excel in your field and make your mark.

  • Profiling Immune Cell and Platelet Transcriptomes

    The identification of a diverse array of GPCRs in immune cells underscores their potential roles in modulating expression of chemokine receptors in monocytes and macrophages suggest that these GPCRs could be targeted to modulate As the field continues to evolve, the insights gained from this research will be instrumental in shaping

  • 📰 GPCR Weekly News, April 15 to 21, 2024

    GPCRs in Neuroscience Calcium-sensing receptor regulates Kv7 channels via Gi/o protein signalling and modulates metamorphosis and spawning behavior in Pacific abalone The role of orphan G protein-coupled receptors in pain

bottom of page